Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) — United States, October 2017–June 2018

Elisabeth M. Hesse(Epidemic Intelligence Service), Maria Cano(National Center for Emerging and Zoonotic Infectious Diseases)

MMWR Morbidity and Mortality Weekly Report

January 31, 2019

10.15585/mmwr.mm6804a4

Cited by 61

Related Papers

Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.

|PubMed|2014|537